Selection and Management of Ventricular Assist Device Patients: The Muenster Experience

Journal of Heart and Lung Transplantation

Volumn 19, Issue 8, 2000, Pages

  Deng, M C ^a,b   Weyand, M ^a   Hammel, D ^a   Schmid, C ^a   Kerber, S ^a   Schmidt, C ^a   Breithardt, G ^a   Scheld, H H ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Milstein Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASSISTED CIRCULATION; CLINICAL FEATURE; CONTROLLED STUDY; DEVICE; DISEASE SEVERITY; FEMALE; HEART INDEX; HEART TRANSPLANTATION; HUMAN; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SURVIVAL;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PREOPERATIVE CARE; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0034632649     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1053-2498(99)00112-6     Document Type: Article

References (16)

1. Deng MC, Breithardt G, Scheld HH. Interdisciplinary heart failure and transplant program Munster: a 5-year experience. Int J Cardiol 1995;50:7-17.
2. Schmid C, Nabavi DG, Georgiadis D, et al. Systemic embolization during Novacor LVAD support (abstract). J Heart Lung Transplant 1996;15:S87.
3. Nabavi D, Georgiadis D, Mumme T, et al. Clinical relevance of intracranial microembolic signals in patients with left ventricular assist devices. Stroke 1996;27:891-6.
4. Termuhlen DF, Pennington DG, Roodman ST, et al. T cells in ventricular assist device patients. Circulation 1989;80: (suppl III):III174-82.
5. Deng MC, Tamminga N, Erren M, Weyand M, Hammel D, Scheld HH. Persistent inflammation and temporary immunosuppression in LVAS-patients: implications for management (abstract). J Heart Lung Transplant 1997;16:105.
6. Weyend M, Hermann M, Hammel D, Deng MC, Scheld HH. Computer tomographic (CT)-positive strokes in left ventricular assist (LVAD) recipients: incidence, pathogenesis and outcome (abstract). J Heart Lung Transplant 1997;16:79.
7. Ramasamy N, Portner PM. Novacor LVAS: results with bridge to transplant and chronic support (state-of-the-art-review). Cardiac Surg 1993;7:363-76.
8. Deng MC, Kammerling L, Erren M, et al. Relation of interleukin(IL)-6, tumor-necrosis factor-α, IL-2 and IL-2 receptor-levels to cellular rejection, allograft dysfunction and mortality early after cardiac transplantation. Transplantation 1995;60:1118-24.
9. Pae WE, Jr. Ventricular assist devices and total artificial hearts: a combined registry experience. Ann Thorac Surg 1993;55:295-8.
10. Smith JA, Opyer PE, Stinson EB, Portner PM, Reitz BA, Shumway N. Bridging to cardiac transplantation with the Novacor left ventricular assist system. Asia Pacific J Thorac Cardiovasc Surg 1994;3:17-24.
11. McCarthy PM, Sabik JF. Implantable circulatory support devices as a bridge to heart transplantation. Sem Thorac Cardiovasc Surg 1994;6:174-80.
12. Kormos RL, Murali S, Dew MA, et al. Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival. Ann Thorac Surg 1994;57:51-8.
13. Reedy JE, Swartz MT, Termuhlen DF, et al. Bridge to transplantation: importance of patient selection. J Heart Lung Transplant 1990;9:473-81.
14. Farrar DJ, Lawson JH, Litwak P, Cederwall G. Thoratec VAD system as a bridge to heart transplantation. J Heart Transplant 1990;9:415-23.
15. Farrar DJ, and Thoratec Ventricular Assist Device Principal Investigators. Preoperative predictors of survival in patients with Thoractec ventricular assist devices as a bridge to heart transplantation. J Heart Lung Transplant 1994;13:93-101.
16. Deng MC, Gradaus R, Weyand M, et al. Heart transplant candidates at high risk can be identified at the time of initial evaluation. Transplant Int 1996;9:38-45.